Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allan J Goodman

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Chemmedchem|October 9, 2007
Mu opioid receptor antagonists: recent developmentsAllan J Goodman, Bertrand Le Bourdonnec, Roland E Dolle
Journal of Combinatorial Chemistry|September 1, 2009
Comprehensive survey of chemical libraries for drug discovery and chemical biology: 2008Roland E Dolle, Bertrand Le Bourdonnec, Allan J Goodman, et al.
Journal of Combinatorial Chemistry|November 11, 2008
Comprehensive survey of chemical libraries for drug discovery and chemical biology: 2007Roland E Dolle, Bertrand Le Bourdonnec, Allan J Goodman, et al.
Journal of Combinatorial Chemistry|September 20, 2007
Comprehensive survey of chemical libraries for drug discovery and chemical biology: 2006Roland E Dolle, Bertrand Le Bourdonnec, Allan J Goodman, et al.
Organic Letters|January 30, 2004
Model systems for flavoenzyme activity: interplay of hydrogen bonding and aromatic stacking in cofactor redox modulationMark Gray, Allan J Goodman, Joseph B Carroll, et al.
Journal of Natural Products|September 18, 2014
Development of a fluorescence assay for the characterization of brevenal binding to rat brain synaptosomesJennifer R McCall, Allan J Goodman, Henry M Jacocks, et al.
Journal of Medicinal Chemistry|December 8, 2006
Synthesis and pharmacological evaluation of novel octahydro-1H-pyrido[1,2-a]pyrazine as mu-opioid receptor antagonistsBertrand Le Bourdonnec, Allan J Goodman, Thomas M Graczyk, et al.
Bioorganic & Medicinal Chemistry Letters|November 22, 2005
Synthesis and structure-activity relationships of a new series of 2alpha-substituted trans-4,5-dimethyl-4-(3-hydroxyphenyl)piperidine as mu-selective opioid antagonistsBertrand Le Bourdonnec, Allan J Goodman, Mathieu Michaut, et al.
Journal of Medicinal Chemistry|December 8, 2006
Elucidation of the bioactive conformation of the N-substituted trans-3,4-dimethyl-4-(3-hydroxyphenyl)piperidine class of mu-opioid receptor antagonistsBertrand Le Bourdonnec, Allan J Goodman, Mathieu Michaut, et al.
Bioorganic & Medicinal Chemistry Letters|September 9, 2009
Novel pyridine derivatives as potent and selective CB2 cannabinoid receptor agonistsGuo-Hua Chu, Christopher T Saeui, Karin Worm, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Chemmedchem|October 9, 2007
Mu opioid receptor antagonists: recent developmentsAllan J Goodman, Bertrand Le Bourdonnec, Roland E Dolle
Journal of Combinatorial Chemistry|September 1, 2009
Comprehensive survey of chemical libraries for drug discovery and chemical biology: 2008Roland E Dolle, Bertrand Le Bourdonnec, Allan J Goodman, et al.
Journal of Combinatorial Chemistry|November 11, 2008
Comprehensive survey of chemical libraries for drug discovery and chemical biology: 2007Roland E Dolle, Bertrand Le Bourdonnec, Allan J Goodman, et al.
Journal of Combinatorial Chemistry|September 20, 2007
Comprehensive survey of chemical libraries for drug discovery and chemical biology: 2006Roland E Dolle, Bertrand Le Bourdonnec, Allan J Goodman, et al.
Organic Letters|January 30, 2004
Model systems for flavoenzyme activity: interplay of hydrogen bonding and aromatic stacking in cofactor redox modulationMark Gray, Allan J Goodman, Joseph B Carroll, et al.
Journal of Natural Products|September 18, 2014
Development of a fluorescence assay for the characterization of brevenal binding to rat brain synaptosomesJennifer R McCall, Allan J Goodman, Henry M Jacocks, et al.
Journal of Medicinal Chemistry|December 8, 2006
Synthesis and pharmacological evaluation of novel octahydro-1H-pyrido[1,2-a]pyrazine as mu-opioid receptor antagonistsBertrand Le Bourdonnec, Allan J Goodman, Thomas M Graczyk, et al.
Bioorganic & Medicinal Chemistry Letters|November 22, 2005
Synthesis and structure-activity relationships of a new series of 2alpha-substituted trans-4,5-dimethyl-4-(3-hydroxyphenyl)piperidine as mu-selective opioid antagonistsBertrand Le Bourdonnec, Allan J Goodman, Mathieu Michaut, et al.
Journal of Medicinal Chemistry|December 8, 2006
Elucidation of the bioactive conformation of the N-substituted trans-3,4-dimethyl-4-(3-hydroxyphenyl)piperidine class of mu-opioid receptor antagonistsBertrand Le Bourdonnec, Allan J Goodman, Mathieu Michaut, et al.
Bioorganic & Medicinal Chemistry Letters|September 9, 2009
Novel pyridine derivatives as potent and selective CB2 cannabinoid receptor agonistsGuo-Hua Chu, Christopher T Saeui, Karin Worm, et al.
Pageof 2